The global medical bionic implants and exoskeletons market stood at U$ 454.5 Mn in 2016. It is expected to expand at a CAGR of 7.5% during the period 2017-2027 to reach U$ 1,001.4 Mn. Factors such as rising amputation rates, diabetes, arthritis, trauma cases and expanding ageing demographics have led to a higher number of bionic implants and exoskeletons procedures. According to National Center for Health Statistics, 185,000 new amputations are consistently being performed in the U.S every year. Advancement in new robotics technology (mind-controlled bionic limbs & exoskeletons) coupled with 3D printing is also positively impacting the growth of the market.
This is just the market for addressing a disability or impairment (aka “fixing”). There will be a market for intentional augmentation (aka “improving”).